$RLYB
Rallybio Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT
RLYB chart
What traders are saying about $RLYB
Latest postsRallybio Corp news
- Rallybio 2026: Revenue $0 Net income ($2.73M), EPS ($0.48) — 10-Q Summary
TradingView ·
- Revenue falls to zero as Rallybio (RLYB) swings from a $16M quarterly profit to a loss.
Stock Titan ·
- A merger-linked cash payout from Rallybio (RLYB) hinges on a November 4 stockholder vote.
Stock Titan ·
- Rallybio announces special cash distribution tied to merger with Avenzo
Investing.com ·
- Rallybio Declares Estimated $82.7 Million Special Cash Distribution
TradingView ·
- A November 4 stockholder vote stands between Rallybio (RLYB) holders and a special cash payout.
Stock Titan ·
- Rallybio Corporation Estimates – NASDAQ:RLYB
TradingView ·
- Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
Business Wire ·
- Form 4 Rallybio Corp: Paula Soteropoulos (Director) For: 16 October By Investing.com
Investing.com South Africa ·
- Form 4 Rallybio Corp: Helen M. Boudreau (Director) For: 16 October
Investing.com Canada ·
- VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical Development
Yahoo Finance ·
- Prolium Bioscience Sclerosis, Lupus Treatment Studies Advancing
Yahoo Finance ·
Rallybio Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $858,000 | $636,000 | – | – |
| Net income | -$9.0M | -$57.8M | -$74.6M | -$66.7M |
| Diluted EPS | $-1.59 | $-10.61 | $-1.84 | $-2.09 |
| Total assets (year end) | $62.3M | $68.1M | $115.6M | $180.4M |
| Cash and equivalents (year end) | $31.4M | $13.9M | $24.5M | $57.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rallybio Corp
- Ticker
- RLYB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1739410
- Former names
- Rallybio Holdings, LLC
Frequently asked questions
What exchange is Rallybio Corp listed on?
Rallybio Corp trades on the Nasdaq under the ticker symbol RLYB.
What industry is Rallybio Corp in?
Rallybio Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rallybio Corp headquartered?
Rallybio Corp's business address on file with the SEC is in New Haven, CT.
When does Rallybio Corp's fiscal year end?
Rallybio Corp's fiscal year ends on December 31.
How much revenue did Rallybio Corp report?
Rallybio Corp reported $858,000 in revenue for calendar year 2025, according to its SEC filings.